Dashboard
Manage Tickers

HOOKHOOKIPA Pharma Inc.

Nasdaq www.hookipapharma.com


$ 0.73 $ -0.04 (-4.92 %)    

Friday, 14-Jun-2024 15:52:11 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.30 $ 2.47 (0.52 %)
DIA $ 386.46 $ -0.42 (-0.11 %)
SPY $ 542.65 $ 0.33 (0.06 %)
TLT $ 94.67 $ 0.79 (0.84 %)
GLD $ 215.76 $ 2.76 (1.3 %)
$ 0.7435
$ 0.78
$ 0.00 x 0
$ 0.00 x 0
$ 0.72 - $ 0.78
$ 0.41 - $ 1.14
578,622
na
73.57M
$ 0.82
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 03-22-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 03-15-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-11-2022 06-30-2022 10-Q
9 05-16-2022 03-31-2022 10-Q
10 03-24-2022 12-31-2021 10-K
11 11-10-2021 09-30-2021 10-Q
12 08-12-2021 06-30-2021 10-Q
13 05-12-2021 03-31-2021 10-Q
14 03-18-2021 12-31-2020 10-K
15 11-12-2020 09-30-2020 10-Q
16 08-13-2020 06-30-2020 10-Q
17 05-14-2020 03-31-2020 10-Q
18 03-19-2020 12-31-2019 10-K
19 11-12-2019 09-30-2019 10-Q
20 08-12-2019 06-30-2019 10-Q
21 05-20-2019 03-31-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

keurig-dr-pepper-to-rally-around-18-here-are-10-top-analyst-forecasts-for-wednesday
Keurig Dr Pepper To Rally Around 18%? Here...
06/05/2024 12:40:48

hc-wainwright--co-maintains-buy-on-hookipa-pharma-raises-price-target-to-6
HC Wainwright & Co. Maintains Buy on HOOKI...
06/05/2024 11:39:38

HC Wainwright & Co. analyst Arthur He maintains HOOKIPA Pharma (NASDAQ:HOOK) with a Buy and raises the price target from...

hookipa-pharma-announces-phase-2-results-for-hb-200-combined-with-pembrolizumab-in-hpv16-head-and-neck-cancer
HOOKIPA Pharma Announces Phase 2 Results F...
06/04/2024 17:03:31

Encouraging clinical activity with observed deepening of responses in 35 evaluable first line head and neck patients treated wi...

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
05/27/2024 16:31:22

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
05/24/2024 16:31:03

deep-dive-into-hookipa-pharma-stock-analyst-perspectives-4-ratings
Deep Dive Into HOOKIPA Pharma Stock: Analy...
05/21/2024 19:00:30

rbc-capital-reiterates-outperform-on-hookipa-pharma-maintains-5-price-target
RBC Capital Reiterates Outperform on HOOKI...
05/21/2024 17:10:27

RBC Capital analyst Brian Abrahams reiterates HOOKIPA Pharma (NASDAQ:HOOK) with a Outperform and maintains $5 price target.

hookipa-pharma-q1-2024-gaap-eps-011-beats-010-estimate-sales-36599m-beat-2800m-estimate
HOOKIPA Pharma Q1 2024 GAAP EPS $0.11 Beat...
05/09/2024 11:15:43

HOOKIPA Pharma (NASDAQ:HOOK) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $(0.10...

breaking-down-hookipa-pharma-4-analysts-share-their-views
Breaking Down HOOKIPA Pharma: 4 Analysts S...
04/26/2024 12:00:23

hc-wainwright--co-maintains-buy-on-hookipa-pharma-lowers-price-target-to-5
HC Wainwright & Co. Maintains Buy on HOOKI...
04/26/2024 10:55:31

HC Wainwright & Co. analyst Arthur He maintains HOOKIPA Pharma (NASDAQ:HOOK) with a Buy and lowers the price target from...

hookipa-pharma-announced-its-final-pivotal-phase-23-trial-design-for-hb-200-in-combination-with-pembrolizumab-based-on-alignment-with-the-fda
HOOKIPA Pharma Announced Its Final Pivotal...
04/25/2024 11:24:43

why-is-penny-stock-hookipa-pharma-trading-higher-on-wednesday
Why Is Penny Stock HOOKIPA Pharma Trading ...
04/24/2024 14:31:37

HOOKIPA Pharma secures FDA clearance for its innovative HB-700 therapeutic vaccine targeting KRAS-mutated cancers. Learn about ...

hookipa-pharma-shares-are-trading-higher-after-the-company-received-fda-clearance-for-its-ind-application-for-hb-700
HOOKIPA Pharma shares are trading higher a...
04/24/2024 11:51:18

hookipa-pharma-received-fda-clearance-for-its-investigational-new-drug-application-for-hb-700-an-arenaviral-therapeutic-vaccine-for-kras-mutated-cancers
HOOKIPA Pharma Received FDA Clearance For ...
04/24/2024 11:02:36

roches-lymphoma-drug-with-chemo-extends-survival-in-pretreated-patients
Roche's Lymphoma Drug With Chemo Extends S...
04/15/2024 12:56:25

Roche study results show prolonged survival in R/R diffuse large B-cell lymphoma patients treated with Columvi (glofitamab) + G...

hookipa-pharma-announced-that-members-of-its-executive-team-will-host-an-investor-call-summarizing-the-companys-constructive-regulatory-interactions-with-the-us-food--drug-administration-fda-and-the-european-medicines-agency-ema
HOOKIPA Pharma Announced That Members Of I...
04/10/2024 11:10:35

rbc-capital-reiterates-outperform-on-hookipa-pharma-maintains-5-price-target
RBC Capital Reiterates Outperform on HOOKI...
03/25/2024 14:25:13

RBC Capital analyst Brian Abrahams reiterates HOOKIPA Pharma (NASDAQ:HOOK) with a Outperform and maintains $5 price target.

hc-wainwright--co-reiterates-buy-on-hookipa-pharma-maintains-65-price-target
HC Wainwright & Co. Reiterates Buy on HOOK...
03/25/2024 10:25:07

HC Wainwright & Co. analyst Arthur He reiterates HOOKIPA Pharma (NASDAQ:HOOK) with a Buy and maintains $6.5 price target.

hookipa-pharma-q4-earnings-insights
HOOKIPA Pharma: Q4 Earnings Insights
03/22/2024 13:20:05

hookipa-pharma-q4-eps-022-misses-019-estimate-sales-741m-beat-455m-estimate-cash-balance-of-1175m
HOOKIPA Pharma Q4 EPS $(0.22) Misses $(0.1...
03/22/2024 11:03:38

HOOKIPA Pharma (NASDAQ:HOOK) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0....

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)